Methylene blue as an early diagnostic marker for oral precancer and cancer
Open Access
- 9 March 2013
- journal article
- research article
- Published by Springer Nature in SpringerPlus
- Vol. 2 (1) , 95
Abstract
Oral cancer is one of the most common neoplasm’s and is ranked eighth in the cancer incidence worldwide. Early detection is of critical importance because survival rates markedly improve. In vivo staining is a simple, inexpensive, and fairly sensitive method. Involved 120 patients (50 with Premalignant Lesion, 50 with OSCC and 20 controls) stained by Methylene Blue (MB). The results of MB uptake were compared with a simultaneous biopsy of these lesions. Pathologically confirmed precancers and cancers were the positive targets of this screening, while hyperkeratosis without dysplasia and no evidence of malignancy were sorted as negative subjects of screening. The results revealed sensitivity of 91.4%, specificity of 66.6%, positive predictive value 97.7% and negative predictive value 33% leading to diagnostic accuracy of MB stain to 90%. We state that MB staining is useful diagnostic tool in community oral cancer screening programmes for high-risk individuals.Keywords
This publication has 23 references indexed in Scilit:
- Critical evaluation of diagnostic aids for the detection of oral cancerOral Oncology, 2008
- Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesionsBritish Journal of Oral and Maxillofacial Surgery, 2007
- Nomenclature and classification of potentially malignant disorders of the oral mucosaJournal of Oral Pathology & Medicine, 2007
- Oral CancerMayo Clinic Proceedings, 2007
- Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosisGut, 2003
- Characterization of the Binding of Methylene Blue to DNA by Spectroscopic MethodsAnalytical Letters, 2000
- Methylene blue selectively stains intestinal metaplasia in Barrett's esophagusGastrointestinal Endoscopy, 1996
- Sensitivity and specificity of OraScan® toluidine blue mouthrinse in the detection of oral cancer and precancerJournal of Oral Pathology & Medicine, 1996
- Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancyJournal of Oral Pathology & Medicine, 1992
- Diagnosis of Clinically Occult Bladder Cancer by in vivo Staining with Methylene BlueBritish Journal of Urology, 1990